Authors: LEGUELLEC C GAUDET ML LAMANETRE S BRETEAU M

Citation: C. Leguellec et al., STABILITY OF RIFAMPIN IN PLASMA - CONSEQUENCES FOR THERAPEUTIC MONITORING AND PHARMACOKINETIC STUDIES, Therapeutic drug monitoring, 19(6), 1997, pp. 669-674

Authors: VAILLANT L LEGUELLEC C BARRUET R JEHL F RENAULTGALLION C SORENSEN H AUTRET E ROIRON R LORETTE G

Citation: L. Vaillant et al., DIFFUSION OF FUSIDIC ACID (FA), OXACILLIN (O) AND PRISTINAMYCIN (P) IN INTERSTITIAL DERMAL FLUID AFTER REPEATED ORAL-ADMINISTRATION, Journal of investigative dermatology, 108(5), 1997, pp. 18-18

Authors: RATEAU J ELATAOUI K ARSENE S DELAIGUE O LEGUELLEC C ROSSAZZA C

Citation: J. Rateau et al., CONCENTRATION AND STABILITY OF AMPHOTERICIN-B IN A MEDIUM FOR CORNEALSTORAGE AT 31-DEGREES-C (INOSOL-DEGREES) - MEASUREMENTS BY HPLC, Vision research, 36, 1996, pp. 2334-2334

Authors: LEGUELLEC C LACARELLE B VILLARD PH POINT H CATALIN J DURAND A

Citation: C. Leguellec et al., GLUCURONIDATION OF PROPOFOL IN MICROSOMAL FRACTIONS FROM VARIOUS TISSUES AND SPECIES INCLUDING HUMANS - EFFECT OF DIFFERENT DRUGS, Anesthesia and analgesia, 81(4), 1995, pp. 855-861

Authors: LACARELLE B LEGUELLEC C MOREL A ALBANESE J ALAZIA M BALLEREAU M LLURENS M BRUNO R FRANCOIS G DURAND A

Citation: B. Lacarelle et al., MONITORING OF PEFLOXACIN SERUM CONCENTRATIONS IN INTENSIVE-CARE UNIT PATIENTS - COMPARISON OF A NEW IMMUNOASSAY WITH HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Therapeutic drug monitoring, 16(2), 1994, pp. 209-213

Authors: LEGUELLEC C LACARELLE B CATALIN J DURAND A

Citation: C. Leguellec et al., INHIBITORY EFFECTS OF ANTICANCER DRUGS ON DEXTROMETHORPHAN-O-DEMETHYLASE ACTIVITY IN HUMAN LIVER-MICROSOMES, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 491-495